Immunohistochemistry and Molecular Diagnostics of Pleural Malignant Mesothelioma

Differential microRNA expression in pleural mesothelioma: Implications for early detection and prognostication

(2017) H. I. Pass et al.   JOURNAL OF CLINICAL ONCOLOGY

Asbestos, Lung Cancers, and Mesotheliomas

(2010) Nicholas H. Heintz et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma

(2010) Gretchen V. Gee et al.   INTERNATIONAL JOURNAL OF CANCER

Sarcomatoid mesothelioma: a clinical–pathologic correlation of 326 cases

(2010) Sonja Klebe et al.   MODERN PATHOLOGY

9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis

(2010) Maiko Takeda et al.   PATHOLOGY INTERNATIONAL

Podoplanin is a Better Immunohistochemical Marker for Sarcomatoid Mesothelioma Than Calretinin

(2009) Diana M. Padgett et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Tenascin-X is a Novel Diagnostic Marker of Malignant Mesothelioma

(2009) Yuan Yuan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Differentiation of Lung Adenocarcinoma, Pleural Mesothelioma, and Nonmalignant Pulmonary Tissues Using DNA Methylation Profiles

(2009) B. C. Christensen et al.   CANCER RESEARCH

Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma

(2009) Y. Goto et al.   CANCER RESEARCH

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

(2009) A. Scherpereel et al.   EUROPEAN RESPIRATORY JOURNAL

CDKN2A,NF2, andJUNare dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis

(2009) Mohamed Guled et al.   GENES CHROMOSOMES & CANCER

Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma

(2009) Vishwa Jeet Amatya et al.   HISTOPATHOLOGY

Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma

(2009) Yukio Takeshima et al.   HISTOPATHOLOGY

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

(2009) Justin A. Bishop et al.   HUMAN PATHOLOGY

Diagnosis of epithelial mesothelioma using tree-based regression analysis and a minimal panel of antibodies

(2009) Sonja Klebe et al.   PATHOLOGY

Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype

(2009) Oluf Dimitri Røe et al.   PLoS One

9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis

(2008) Fabiana Botelho de Miranda Onofre et al.   CANCER

Recent Mortality from Pleural Mesothelioma, Historical Patterns of Asbestos Use, and Adoption of Bans: A Global Assessment

(2008) Kunihito Nishikawa et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Genomic events associated with progression of pleural malignant mesothelioma

(2008) Sergey V. Ivanov et al.   INTERNATIONAL JOURNAL OF CANCER

Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review

(2008) Sonja Klebe et al.   MODERN PATHOLOGY

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas

(2008) Simion Chiosea et al.   MODERN PATHOLOGY

Emerging methods for analysis of the cancer methylome

(2008) Jer-Wei Chang et al.   PHARMACOGENOMICS